Project Aim

The aim of this project was to investigate the impact of gene therapy for Leber Congenital Amaurosis (LCA) using a dog model of the disease.

Project Results and Impact

Following gene therapy, the vision impaired dogs showed remarkable improvement in their sight. After this success, the team focused its attention on Age Related Macular Degeneration (AMD).

Professor Rakoczy and her team developed a promising approach called Secretion Gene Therapy to treat wet AMD. Their preclinical trials have shown positive results in inhibiting the growth of harmful blood vessels and maintaining vision. They are now seeking approval to conduct human trials in Australia, with the aim of starting clinical trials soon.

Chief investigator:
Professor Elizabeth Rakoczy
Research at Lions Eye Institute, University of Western Australia

Grant awarded:
$60,000 (2007)

Research Impact Reports

Establishing novel AAV gene editing for Usher Syndrome

Project Aim The aim of this project was to establish proof-of-concept for a new type...

Using RNA-silencing to tackle neuroinflammation in retinal degeneration

Project Aim  The aim of this project was to develop...

Improving real-world mobility and assessing long-term safety outcomes with a retinal prosthesis (“Bionic Eye”)

Project Aim This project aimed to measure visual outcomes of...

RNA base editing strategies as potential therapeutic of inherited retinal dystrophies

Project Aim This study aimed to use a new genetic...